CIK: 0001602263
Total reported value
$379.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Avexis INC | Stock-Other | 22.81% | — | — | |
| 2 | EWTX | Edgewise Therapeutics, Inc. | Stock-Other | 11.80% | — | — | |
| 3 | ✓ | DBV Technologies | Stock-Other | 10.52% | — | +74.25% | |
| 4 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 9.81% | -3.14% | EXIT | |
| 5 | ASND | Ascendis Pharma A/S | Stock-Other | 5.78% | -8.61% | EXIT | |
| 6 | RGNX | Regenxbio INC | Stock-Other | 4.83% | — | -3.04% | |
| 7 | HRTX | Heron Therapeutics INC | Stock-Other | 4.42% | — | — | |
| 8 | ✓ | Alcobra Ltd | Stock-Other | 3.94% | — | +28.65% | |
| 9 | CTMX | Cytomx Therapeutics INC | Stock-Other | 3.56% | — | — | |
| 10 | ✓ | Axovant Sciences LTD | Stock-Other | 3.33% | — | — | |
| 11 | ✓ | Stock-Other | 3.01% | — | — | ||
| 12 | CHRS | Coherus Oncology INC | Stock-Other | 2.64% | — | — | |
| 13 | ✓ | Cynapsus Therapeutics INC | Stock-Other | 2.54% | — | — | |
| 14 | ONC | Beone Medicines Ltd-adr | Stock-Other | 2.14% | — | — | |
| 15 | ✓ | ARCA biopharma Inc | Stock-Other | 1.89% | — | — | |
| 16 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 1.71% | — | — | |
| 17 | STMLEUR | Stemline Therapeutics INC | Stock-Other | 1.29% | — | — | |
| 18 | ✓ | Ocera Therapeutics INC | Stock-Other | 1.09% | — | — | |
| 19 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 0.92% | — | — | |
| 20 | ✓ | Lipocine INC New | Stock-Other | 0.77% | — | — | |
| 21 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 0.53% | +1.16% | NEW | |
| 22 | ZFGNUSD | Zafgen INC | Stock-Other | 0.51% | — | — | |
| 23 | ✓ | Pronai Therapeutics INC | Stock-Other | 0.16% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Avexis INC | +6.7% | — | Unchanged |
| 2 | ✓ | DBV Technologies | +2.5% | +74.25% | Add |
| 3 | ✓ | Alcobra Ltd | +1.1% | +28.65% | Add |
| 4 | BCRX | Biocryst Pharmaceuticals INC | +1.1% | +22.00% | Add |
| 5 | ✓ | Cynapsus Therapeutics INC | +0.5% | — | Unchanged |
| 6 | STMLEUR | Stemline Therapeutics INC | +0.3% | — | Unchanged |
| 7 | EWTX | Edgewise Therapeutics, Inc. | +0.2% | — | Unchanged |
| 8 | ✓ | Axovant Sciences LTD | +0.1% | — | Unchanged |
| 9 | GBTUSD | Global Blood Therapeutics In | -0.1% | — | Unchanged |
| 10 | ZFGNUSD | Zafgen INC | -0.1% | — | Unchanged |
| 11 | ONC | Beone Medicines Ltd-adr | -0.2% | — | Unchanged |
| 12 | ✓ | -0.4% | — | Unchanged | |
| 13 | ✓ | Pronai Therapeutics INC | -0.4% | — | Unchanged |
| 14 | ✓ | ARCA biopharma Inc | -0.6% | — | Unchanged |
| 15 | HRTX | Heron Therapeutics INC | -0.7% | — | Unchanged |
| 16 | ✓ | Ocera Therapeutics INC | -0.7% | — | Unchanged |
| 17 | CHRS | Coherus Oncology INC | -1% | — | Unchanged |
| 18 | CTMX | Cytomx Therapeutics INC | -1.3% | — | Unchanged |
| 19 | ✓ | Lipocine INC New | -2% | — | Unchanged |
| 20 | RGNX | Regenxbio INC | -2.5% | -3.04% | Trim |
| 21 | ASND | Ascendis Pharma A/S | -3% | — | Unchanged |
| 22 | AGLEUSD | Aeglea Biotherapeutics INC | — | NEW | New buy |
| 23 | AVAZ | 2x Avalanche ETF | — | EXIT | Sold out |
| 24 | ADVMCHF | Adverum Biotechnologies INC | — | NEW | New buy |